Delivery Order SPE2DR25D3011-SPE2DR26FW24E
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,624.15 to AmerisourceBergen Drug Corp for Briviact 75 mg tablets (60-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,857.36 to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count) on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,601.40 to AmerisourceBergen Drug Corp for Briviact 50mg tablets (60-count) on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count units) valued at $3,262.48 on October 20, 2025, with completion targeted for October 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designations and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,799.70 to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60 count) on May 6, 2025, with completion targeted for May 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $4,834.48 to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count units) on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The Defense Logistics Agency awarded a $2,451.23 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Briviact 50 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 27, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,859.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count) on August 26, 2025, with completion targeted for August 27, 2025. This competitively awarded, non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has been selected to...
- The Defense Logistics Agency awarded a delivery order valued at $2,320.35 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count supply) on September 26, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- SPE2DR25D3011Indefinite Delivery Contract
- SPE2DR25D3011-SPE2DR26FW24EDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,743.11 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count) on November 14, 2025, with completion scheduled for November 17, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order supporting federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and federal healthcare systems through its extensive portfolio of medication and medical supply offerings. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including services to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Briviact delivery represents one of numerous pharmaceutical transactions fulfilling federal medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/14/25 |